Switching treatments in clinically stable relapsing remitting multiple sclerosis patients planning for pregnancy

BACKGROUND: The decision to have children can be complex, particularly for people with multiple sclerosis (MS). A key concern is the use of disease modifying drugs (DMDs) during pregnancy, and how continuing, stopping or switching them may affect the mother and child. In people with active MS, stopp...

Descripción completa

Detalles Bibliográficos
Autores principales: Almouzain, Lubna, Stevenson, Fiona, Chard, Declan, Rahman, Nur Abdul, Hamilton, Fiona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985951/
https://www.ncbi.nlm.nih.gov/pubmed/33796332
http://dx.doi.org/10.1177/20552173211001571

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985951/
https://www.ncbi.nlm.nih.gov/pubmed/33796332
http://dx.doi.org/10.1177/20552173211001571

Ejemplares similares